National and provincial impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in China: a modeling analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
National and provincial impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in China: a modeling analysis
Authors
Keywords
-
Journal
BMC Medicine
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-11
DOI
10.1186/s12916-021-02049-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2019) Maigeng Zhou et al. LANCET
- Routine immunization services costs and financing in China, 2015
- (2018) Wenzhou Yu et al. VACCINE
- Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15
- (2018) Brian Wahl et al. Lancet Global Health
- The landscape of vaccines in China: history, classification, supply, and price
- (2018) Yaming Zheng et al. BMC INFECTIOUS DISEASES
- Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effects
- (2018) Keith P. Klugman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cost-Effectiveness of Pediatric Cochlear Implantation in Rural China
- (2017) Jianxin Qiu et al. OTOLOGY & NEUROTOLOGY
- Cost-effectiveness of the Haemophilus influenzae type b vaccine for infants in mainland China
- (2017) Guijun Ning et al. Human Vaccines & Immunotherapeutics
- National and subnational all-cause and cause-specific child mortality in China, 1996–2015: a systematic analysis with implications for the Sustainable Development Goals
- (2017) Chunhua He et al. Lancet Global Health
- Under-5 mortality in 2851 Chinese counties, 1996–2012: a subnational assessment of achieving MDG 4 goals in China
- (2016) Yanping Wang et al. LANCET
- Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research
- (2016) Beth Woods et al. VALUE IN HEALTH
- Causes of death in children younger than five years in China in 2015: an updated analysis
- (2016) Peige Song et al. Journal of Global Health
- To Save Children’s Lives, China Should Adopt An Initiative To Speed Introduction Of Pneumonia Vaccines
- (2013) Hongjie Yu et al. HEALTH AFFAIRS
- Haemophilus influenzae type b (Hib) Vaccination WHO position paper: July 2013-Recommendations
- (2013) VACCINE
- Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trials
- (2012) U. K. GRIFFITHS et al. EPIDEMIOLOGY AND INFECTION
- Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India
- (2012) M. Gupta et al. HEALTH POLICY AND PLANNING
- The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England
- (2012) Albert Jan van Hoek et al. VACCINE
- Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions
- (2010) Orin S Levine et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis
- (2010) Karen Edmond et al. LANCET INFECTIOUS DISEASES
- Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates
- (2009) James P Watt et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started